Javier P Gisbert
Javier P Gisbert is an expert in Gastroenterology at Hospital Universitario de La Princesa (Spain). Javier P Gisbert has authored 1,596 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 5 of them ongoing. SLR score: 6,228 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Pharmacy - Hepatology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 1596
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease. PMID 42860841 — epidemiology, inflammatory bowel diseases, pharmacology, diagnosis, therapeutics, biological therapy, colitis, ulcerative, prospective studies | Aliment Pharmacol Ther | 2026 | 0 |
| Ulcerative colitis, but not Crohn's disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification. PMID 42851492 — cells, colitis, blood, crohn disease, immunophenotyping, immune system diseases, inflammatory bowel diseases, cluster analysis, sex, tissues, mucous membrane, colitis, ulcerative | Front Immunol | 2026 | 0 |
| Biologics, small molecules, and extraintestinal malignancies in inflammatory bowel disease: practical questions and evidence-based answers. PMID 42789488 — ustekinumab, safety, crohn disease, lymphoma, neoplasms, inflammatory bowel diseases, therapeutics, colitis, ulcerative, small molecules | Inflamm Bowel Dis | 2026 | 0 |
| Tofacitinib does not affect platelet function or coagulation in patients with ulcerative colitis. PMID 42787274 — colitis, arthritis, platelet aggregation, immune system diseases, arthritis, rheumatoid, therapeutics, thrombosis, blood platelets, colitis, ulcerative, platelet activation, hemostasis | Front Immunol | 2026 | 0 |
| Outcomes and Reclassification Patterns in Inflammatory Bowel Disease Unclassified: A Multicenter Study Matched With Ulcerative Colitis From Spanish ENEIDA Registry. PMID 42768837 — liver diseases, registries, colitis, gastroenterology, classification, inflammatory bowel diseases, therapeutics, biological therapy, colitis, ulcerative | J Gastroenterol Hepatol | 2026 | 0 |
Clinical Studies 29
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Efficacy and Safety of Icotrokinra in Adult and Adolescent Participants with Moderately to Severely Active Ulcerative Colitis 2025-521381-10-00 — colitis, safety, maintenance, adolescent, therapeutics, colitis, ulcerative | Phase 3 | Recruiting | 2025 |
| Efficacy and Safety of Icotrokinra in Participants with Moderately to Severely Active Crohn s Disease 2025-521382-27-00 — safety, crohn disease, maintenance | Phase 2/Phase 3 | Recruiting | 2025 |
| Safety of IBD Drugs During Pregnancy and Breasfeeding Mothers and Babies Outcomes NCT06337565 — registries, pregnancy, mothers, safety, pharmaceutical preparations | N/A | Recruiting | 2024 |
| Immunological Characteristics of Preclinical IBD NCT05698745 — natural history, colitis, blood, serum, crohn disease, inflammatory bowel diseases, history, tissues, colitis, ulcerative, prospective studies, plasma | N/A | Recruiting | 2024 |
| Effect of Tofacitinib on Coagulation and Platelet Function and Its Role in Thromboembolic Events NCT05313620 — thromboembolism, colitis, pharmaceutical preparations, adalimumab, therapeutics, janus kinase inhibitors, blood platelets, colitis, ulcerative, infliximab | Phase 4 | Recruiting | 2022 |
LeadR Networks
Main global connection map